Dermatan (sulphate sodium), CAS 54328-33-5

Product Description: Dermatan sulphate sodium is a glycosaminoglycan and thrombin inactivator with antithrombotic activity. Dermatan sulphate sodium selectively catalyzes the inactivation of thrombin by heparin cofactor II and does not interact with antithrombin III. Dermatan sulphate sodium is highly bioavailable and also reduces Bleomycin (HY-108345)-induced pulmonary fibrosis damage[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Nenci GG. Dermatan sulphate as an antithrombotic drug. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):303-7. /[2]Xu J, et al. Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis. J Int Med Res. 2019 Jun;47(6):2655-2665.

CAS Number: 54328-33-5

Molecular Weight: N/A

Research Area: Inflammation/Immunology; Cardiovascular Disease

Solubility: DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : 100 mg/mL (ultrasonic)

Target: Thrombin

• Artikelnummer: MEXHY-N8278-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-N8278-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK